Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.jinf.2020.05.046 http://scihub22266oqcxt.onion/10.1016/j.jinf.2020.05.046 32473235!7255350!32473235     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       J+Infect 2020 ; 81 (2): 266-275 Nephropedia Template TP {{tp|p=32473235|t=2020. Co-infections in people with COVID-19: a systematic review and meta-analysis |pdf=|usr=}}{{32473235}} gab.com Text Co-infections in people with COVID-19: a systematic review and meta-analysis JO: J Infect http://www.kidney.de/pget.php?&tw=1&pmid=32473235 #FOAvip OBJECTIVES: In previous influenza pandemics, bacterial co-infections have been a major cause of mortality. We aimed to evaluate the burden of co-infections in patients with COVID-19. METHODS: We systematically searched Embase, Medline, Cochrane Library, LILACS and CINAHL for eligible studies published from 1 January 2020 to 17 April 2020. We included patients of all ages, in all settings. The main outcome was the proportion of patients with a bacterial, fungal or viral co-infection. . RESULTS: Thirty studies including 3834 patients were included. Overall, 7% of hospitalised COVID-19 patients had a bacterial co-infection (95% CI 3-12%, n=2183, I(2)=92.2%). A higher proportion of ICU patients had bacterial co-infections than patients in mixed ward/ICU settings (14%, 95% CI 5-26, I(2)=74.7% versus 4%, 95% CI 1-9, I(2)= 91.7%). The commonest bacteria were Mycoplasma pneumonia, Pseudomonas aeruginosa and Haemophilus influenzae. The pooled proportion with a viral co-infection was 3% (95% CI 1-6, n=1014, I(2)=62.3%), with Respiratory Syncytial Virus and influenza A the commonest. Three studies reported fungal co-infections. CONCLUSIONS: A low proportion of COVID-19 patients have a bacterial co-infection; less than in previous influenza pandemics. These findings do not support the routine use of antibiotics in the management of confirmed COVID-19 infection. Twit Text FOAVip Co-infections in people with COVID-19: a systematic review and meta-analysis ????J Infect http://www.kidney.de/pget.php?&tw=1&pmid=32473235 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32473235 #FOAvip English Wikipedia <ref>{{Cite pmid|32473235}}</ref> Co-infections in people with COVID-19: a systematic review and meta-analysis #MMPMID32473235 Lansbury L; Lim B; Baskaran V; Lim WS J Infect 2020[Aug]; 81 (2): 266-275 PMID32473235show ga OBJECTIVES: In previous influenza pandemics, bacterial co-infections have been a major cause of mortality. We aimed to evaluate the burden of co-infections in patients with COVID-19. METHODS: We systematically searched Embase, Medline, Cochrane Library, LILACS and CINAHL for eligible studies published from 1 January 2020 to 17 April 2020. We included patients of all ages, in all settings. The main outcome was the proportion of patients with a bacterial, fungal or viral co-infection. . RESULTS: Thirty studies including 3834 patients were included. Overall, 7% of hospitalised COVID-19 patients had a bacterial co-infection (95% CI 3-12%, n=2183, I(2)=92.2%). A higher proportion of ICU patients had bacterial co-infections than patients in mixed ward/ICU settings (14%, 95% CI 5-26, I(2)=74.7% versus 4%, 95% CI 1-9, I(2)= 91.7%). The commonest bacteria were Mycoplasma pneumonia, Pseudomonas aeruginosa and Haemophilus influenzae. The pooled proportion with a viral co-infection was 3% (95% CI 1-6, n=1014, I(2)=62.3%), with Respiratory Syncytial Virus and influenza A the commonest. Three studies reported fungal co-infections. CONCLUSIONS: A low proportion of COVID-19 patients have a bacterial co-infection; less than in previous influenza pandemics. These findings do not support the routine use of antibiotics in the management of confirmed COVID-19 infection. |Bacterial Infections/complications/epidemiology/*virology[MESH] |Betacoronavirus[MESH] |COVID-19[MESH] |Coinfection/epidemiology/*microbiology/*virology[MESH] |Coronavirus Infections/complications/epidemiology/*virology[MESH] |Humans[MESH] |Mycoses/complications/epidemiology/virology[MESH] |Pandemics[MESH] |Pneumonia, Viral/complications/epidemiology/*virology[MESH] |SARS-CoV-2[MESH]Co-infections in people with COVID-19: a systematic review and meta-an(epmc).pdf DeepDyve Pubget Overpricing